Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 26 April, 2010 and appeared in  April10ISMPInterview

How does ISMP reach and impact healthcare professionals?

ISMP represents more than 35 years of experience in helping healthcare practitioners keep patients safe. One cornerstone of the Institute's medication error prevention efforts is....

Advertisement

a voluntary practitioner error-reporting program for healthcare professionals to learn about errors happening across the nation, understand their causes, and share "lessons learned" with the healthcare community. Each year, ISMP's national Medication Errors Reporting Program (MERP), receives hundreds of error reports from healthcare professionals.

Other key outreach efforts to healthcare professionals include publishing four ISMP Medication Safety Alert!® newsletters for healthcare professionals and consumers that reach nearly a million total readers; presenting frequent educational programs, including teleconferences on current medication use issues; and offering posters, videos, patient brochures, books and other resources. Healthcare practitioners can access valuable, free medication safety tools such as lists of high alert drugs and potentially dangerous abbreviations on ISMP's website, www.ismp.org.

In addition, ISMP provides confidential consulting to healthcare organizations to help proactively evaluate their medication systems or analyze medication-related sentinel events. The Institute now is certified as a Patient Safety Organization (PSO) by the US Department of Health and Human Services.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 26 April, 2010 and appeared in  April10ISMPInterview

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

2013 Most Popular Articles:

Mortality Risk in Patients with Type 2 Diabetes
Posted May 23, 2013
Bacteria in the Gut Improves the Management of Obesity and Type 2 Diabetes
Posted May 23, 2013
Hypoglycemia Treatment and Prevention Related to Physical Activity
Posted May 31, 2013
Scientist Use Bone Marrow Stem Cells to Cure Type 1 Diabetes
Posted June 06, 2013
Simvastatin Can Reduce the Benefits of Exercise in Active Adults
Posted May 23, 2013
Diabetes Epidemic Growing
Posted May 23, 2013
Co-Q10 May Offset Risk of Diabetes with Statin Use
Posted May 23, 2013
Artificial Sweeteners May Affect Blood Glucose Levels and Insulin Response
Posted June 06, 2013
FDA Advisory Panel Votes to Remove Avandia's Highly Restrictive Label
Posted June 06, 2013
Pros and Cons of Incretin-Based Therapies
Posted May 30, 2013

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control



Search Articles On Diabetes In Control